SOFT TISSUE SARCOMA (EXCLUDING GIST)
Clinical trials for SOFT TISSUE SARCOMA (EXCLUDING GIST) explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMA (EXCLUDING GIST) trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMA (EXCLUDING GIST), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation schedule aims to improve sarcoma control before surgery
Disease control Not yet recruitingThis study tests a shorter, more intense course of radiation given before surgery for soft tissue sarcoma in the arms, legs, or trunk. The goal is to see if this approach can better control the tumor and prevent it from coming back. About 135 adults will receive 15 radiation trea…
Matched conditions: SOFT TISSUE SARCOMA (EXCLUDING GIST)
Phase: PHASE2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated May 17, 2026 06:46 UTC
-
New drug cocktail targets Hard-to-Treat sarcomas
Disease control Not yet recruitingThis study tests a combination of three drugs (liposomal irinotecan, temozolomide, and bevacizumab) in 24 people with advanced soft tissue sarcoma that has come back or not responded to prior treatment. The goal is to see if the combo can slow tumor growth and how safe it is. Par…
Matched conditions: SOFT TISSUE SARCOMA (EXCLUDING GIST)
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 07, 2026 18:43 UTC